ISRG Intuitive Surgical
- Official Name: INTUITIVE SURGICAL, INC.
- Headquarters: 1020 Kifer Road, SUNNYVALE, CA, 94086 US
- CEO: Gary S. Guthart
- Website: intuitive.com
- Key Investor: VANGUARD GROUP INC | 9.11%
- Dedicated Investor: DEUTERIUM CAPITAL MANAGEMENT, LLC | 17.01%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-17 | 1 | Lost by 1.804 | (1.464) - 0.340 | ||
| 2025-07-24 | 2 | Lost by 0.490 | (2.637) - (2.147) | ||
| 2025-07-29 | 2R | Won by 4.831 | 0.627 - (4.204) | ||
| 2025-07-31 | 3 | Won by 1.904 | (0.092) - (1.996) | ||
| 2025-08-07 | 4 | Lost by 4.616 | 0.302 - 4.918 | ||
| 2025-08-07 | 1R | Won by 0.044 | (0.457) - (0.501) | ||
| 2025-08-12 | 3R | Won by 1.526 | 1.135 - (0.391) | ||
| 2025-08-14 | 5 | Won by 4.790 | 1.861 - (2.929) | ||
| 2025-08-21 | 6 | Lost by 3.889 | (1.893) - 1.996 | ||
| 2025-08-21 | 2R | Lost by 1.803 | (1.897) - (0.094) | ||
| 2025-08-26 | 4R | Lost by 1.952 | 1.241 - 3.193 | ||
| 2025-08-28 | 7 | Lost by 2.654 | 0.874 - 3.528 | ||
| 2025-09-03 | 1R | Lost by 5.790 | (5.973) - (0.183) | ||
| 2025-09-04 | 8 | Won by 0.334 | (3.944) - (4.278) | ||
| 2025-09-11 | 9 | Won by 2.287 | 0.292 - (1.995) | ||
| 2025-09-18 | 10 | Lost by 3.416 | (4.060) - (0.644) | ||
| 2025-09-25 | 11 | Won by 2.981 | 0.483 - (2.498) | ||
| 2025-10-02 | 12 | Lost by 4.437 | 1.074 - 5.511 | ||
| 2025-10-09 | 13 | Lost by 1.305 | 0.174 - 1.479 | ||
| 2025-10-16 | 14 | Lost by 0.599 | (2.136) - (1.537) | ||
| 2025-10-23 | 15 | Won by 26.639 TOTW | 22.203 - (4.436) |
Latest News

2 Stocks Down 8% or More That Are Screaming Buys Right Now
You might regret ignoring these companies at current levels.

Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference ...

Are Robots the New Normal? Bet on these ETFs to Invest in the Future
Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.

Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
TransMedics' rapid revenue growth and cheaper valuation face rising margin pressure as heavy investment raises execution risks.

Governments Are Encouraging Industrial Robotic Growth
Robotics ETFs (BOTZ, ROBO, ARKQ) offer early growth, but industrial robotics leads. Weigh QQQ/SPY vs. niche ETF risksâread before investing.

ISRG Stock: The Best House On The Block Costs The Most
In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational exce...

Protean Funds Scandinavia AB August 2026 Partner Letter
Protean Small Cap returned 4.7% in August, outperforming its benchmark index by 0.3%. Since launching in August 2023, the fund has gained 89.8%.

PAHC or LMAT: Which Is the Better Value Stock Right Now?
PAHC vs. LMAT: Which Stock Is the Better Value Option?

MKSI or HOCPY: Which Is the Better Value Stock Right Now?
MKSI vs. HOCPY: Which Stock Is the Better Value Option?

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.

Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GSK to Advance mRNA Influenza Vaccine Into Phase III Development
GSK to advance its mRNA flu vaccine into phase III after phase II study has shown stronger immune responses and good tolerability.

GEHC Wins CE Mark for Photonova Spectra, Expands International Reach
GE HealthCare's Photonova Spectra gains CE Mark, expanding access to its Deep Silicon photon-counting CT technology across Europe and other CE ma...

OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy
Ocugen moves OCU410 into phase III for geographic atrophy, with FDA-aligned study plans. The company expects to file a BLA for OCU410 in 2028.


Envista (NVST) Stock May Be 42% Undervalued On Cash Flow
Envista Holdings arrives at a tricky valuation point for investors, with an intrinsic value estimate from a Discounted Cash Flow (DCF) suggesting the ...

Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of t...

Here's How CVS' Improving Balance Sheet Supports Deleveraging
CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026...

Platauro Metals Corp. - Star Project, Utah
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2026) - Platauro Metals Corp. (TSXV: PURO) (OTCQB: MEXGF) ("Platauro" or the &qu...

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
VAUGHAN, Ontario, September 02, 2026--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see ...

Zentek Ltd. Begins Trading on OTCQX Best Market
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and internati...

1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Ignore
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth...

Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 01 09 2026 - (CGWL)
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of th...

Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rul...


Intuitive Surgical's Worst Stretch in Years Isn't Scaring Wall Street -- Here's What Analysts Are Focused On Instead
The stock has dropped more than 30% this year.

Alcon (SWX:ALC), What Is Behind The Fresh Attention?
Alcon stock reacts to US Medicaid drug pricing agreement New US Medicaid drug pricing agreements involving Alcon (SWX:ALC) and eight other healthcare ...

MiniMed (MMED) Soars on Revenue Growth, Price Target Hike; Hedge Fund Conviction Weakens
MiniMed Group (NASDAQ:MMED) saw its share price increase by 10.66 percent on Tuesday to finish at $22.42 apiece after reporting strong revenues and ea...

Why Did PFE, MMED, DE Stocks Surge To 52-Week Highs Today?
Pfizer gained on vaccine and oncology growth, MiniMed on strong earnings, and Deere on AI-driven agriculture.

How Investors Are Reacting To Merit Medical Systems (MMSI) New Global Operations Leadership Transition
In August 2026, Merit Medical Systems announced that Sheri Lewis would join as Executive Vice President of Global Operations, bringing three decades o...

Zentek Approved for Trading on the OTCQX Best Market
Common shares to trade in the U.S. under new ticker ZTEKF beginning September 2, 2026Guelph, Ontario--(Newsfile Corp. - September 1, 2026) - Zentek Lt...

Medtronic Flirts With A Breakout As Its Spinoff, MiniMed, Hits A Record
Medtronic stock popped Tuesday as its diabetes spinoff MiniMed rallied after both lifted their full-year guidance.

These 2 Stocks Hit New Milestones Today – What’s Driving Retail Enthusiasm?
MiniMed’s first-quarter sales rose 17% to $843 million, while BTIG upgraded Tidewater to ‘Buy’ from ‘Neutral’.

How Is Intuitive Surgical's Stock Performance Compared to Other Health Care Equipment Stocks?
Intuitive Surgical has notably underperformed the Health Care Equipment industry over the past year, but analysts are highly optimistic about the stoc...

MiniMed Group Q1 Earnings Call Highlights
MiniMed Group (NASDAQ:MMED) reported fiscal 2027 first-quarter revenue of $843 million, with organic revenue growth of 15.8%, as demand for its newer ...

Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
Intuitive Surgical is boosting R&D despite macro headwinds, targeting AI, robotics and new procedures to expand its market and drive long-term gro...

Mid-cap biotechs join Trump’s latest round of drug pricing deals
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to meaningfully impact drugm...

Trump lines up MFN deals with nine mid-size pharmas on drug pricing push
These deals will require the companies to provide MFN prices to state Medicaid programmes nationally.

Medtronic Tops Earnings Estimates and Makes $700M Robot Surgeon Investment. Is It Gaining on Intuitive Surgical?
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and announces a $700 million invest...

Intuitive Surgical Vs. SS Innovations: Why You Should Buy The Lesser-Known Indian Competitor
Compare SS Innovations vs. Intuitive Surgical in medical roboticsâwhy SS Innovations may offer asymmetric upside, stronger growth, and better ret...